便秘与分娩方式的关联:基于问卷的回顾性研究
G Marije Hierink1,2, Lauret A M Brinkman1, G G Alec Malmberg2
1Department of Surgery, Anorectal Physiology Laboratory, University of Groningen, University Medical Center Groningen, Hanzeplein 1, PO Box 30 001, 9700 RB, Groningen, The Netherlands.
International urogynecology journal
|June 7, 2024
概括
经过阴道分娩的女性比剖腹产的女性更容易出现便秘. 阴道分娩期间的围流进一步增加了便秘的风险.
科学领域:
- 产科和妇科 产科和妇科
- 胃肠病学 胃肠病学
- 盆地健康 盆地健康
背景情况:
- 盆地损伤可能导致盆地功能障碍,包括便秘.
- 关于分娩方式对便秘的影响的研究有限,特别是在怀孕期间之外.
研究的目的:
- 为了调查分娩方式 (阴道与剖腹产) 与产后妇女便秘的患病率之间的关联.
- 为了确定阴道分娩期间围流是否会影响便秘的风险.
主要方法:
- 在荷兰对2,643名孕妇进行了回顾性,横截面,多中心的研究.
- 使用格罗宁根排便和便禁欲调查问卷来评估肠道问题.
- 统计分析包括参数测试,奇平方和回归分析.
主要成果:
- 24.6%的妇女报告了便秘;在阴道分娩组 (25.5%) 的患病率高于剖腹产组 (19.0%).
- 阴道分娩与便秘 (1.47) 的几率比率增加有关.
- 自发的围撕裂使便秘的几率比率增加了1.4倍.
结论:
- 与有阴道分娩史的女性相比,与有剖腹产史的女性相比,阴道分娩的女性的便秘率更高.
- 阴道分娩期间持续存在的围流是导致便秘的重要危险因素.
相关概念视频
Drugs for Treatment of Constipation-Predominant IBS
157
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
157
Assessment of the Rectum and Anus
196
Evaluating the rectum and anus plays a crucial role in conducting a thorough physical examination of the gastrointestinal system. Although it may be uncomfortable and often embarrassing for the patient, it holds immense diagnostic value, particularly in detecting gastrointestinal diseases and abnormalities. This guide will explain how to perform this assessment using inspection and palpation methods.
Rectal Inspection
Begin by inspecting the perianal and anal areas for color, texture, rashes,...
Rectal Inspection
Begin by inspecting the perianal and anal areas for color, texture, rashes,...
196
Drugs Affecting GI Tract Motility: Bulk-Forming and Stimulant Laxatives
203
Laxatives enhance bowel movements and alleviate constipation. They augment the stool's bulk, stimulate intestinal muscle contractions, draw water into the intestines, or soften the stool. There are five key types of laxatives: bulk laxatives, stimulant laxatives, osmotic laxatives, stool softeners, and lubricant laxatives.
Bulk-forming laxatives, such as psyllium, methylcellulose, and polycarbophil, absorb water in the intestine, increasing stool bulk and promoting bowel movement. This...
Bulk-forming laxatives, such as psyllium, methylcellulose, and polycarbophil, absorb water in the intestine, increasing stool bulk and promoting bowel movement. This...
203
Drugs Affecting GI Tract Motility: Other Laxatives
196
Laxatives are primarily used to alleviate constipation, a common gastrointestinal disorder characterized by infrequent bowel movements and difficulty passing stools. They work by various mechanisms to increase the volume or frequency of bowel movements. The primary modes of action of laxatives include increasing stool bulk, softening the stool, stimulating intestinal motility, and osmotically drawing water into the intestines.
Osmotic or saline laxatives, like magnesium hydroxide or milk of...
Osmotic or saline laxatives, like magnesium hydroxide or milk of...
196
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
156
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
156
Drugs for Treatment of Diarrhea-Predominant IBS
159
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
159


